Gossamer Bio, Inc. Common Stock (NASDAQ: GOSS) last traded at $9.19, down 1.29% on the session. The quote above updates while this page is open; the figures below are drawn from Gossamer Bio, Inc. Common Stock’s own filings and are restated only when a new one is published.
Gossamer Bio, Inc. Common Stock trades on NASDAQ under the ticker GOSS. Its market capitalisation is $4.49 billion.
Valuation measures for Gossamer Bio, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $4.49B |
|---|---|
| Enterprise value | $4.62B |
| Price / sales | 84.31 |
| Beta | 2.17 |
Trailing-twelve-month figures tagged in Gossamer Bio, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $53.29M |
| Net income (TTM) | -$125.22M |
|---|
| Operating margin | -311.70% |
|---|
| Cash | $41.15M |
|---|
Range and volume for GOSS over the past 52 weeks.
| 52-week high | $309.60 |
|---|---|
| 52-week low | $8.99 |
| Volume | 125.8K |
| Average volume | 376.5K |
| Previous close | $9.31 |
Invest a chosen dollar amount in Gossamer Bio, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell GOSS.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.